Southern Light Rail is ranked #1 of 7 medical research organizations in Atlanta, GA, with an America's Best Score of 78 out of 100, based on its 2025 Form 990.
Southern Light Rail is a 501(c)(3) organization, classified under Medical Research (NTEE H022). Contributions are tax-deductible.
225 North Avenue Lyman Hall Ste 315, Atlanta, GA 30332-0001
Among the 12 scored medical research organizations in Atlanta, Southern Light Rail holds 16.5 months of operating reserves (peer median 7.8 months), runs a typical yearly surplus of 2.3% (peers: deficit of 3.0%), and has grown spending 8.2% a year (peers: grown spending 13.1% a year).
In fiscal year 2025 it reported $3,865,463 in revenue and $3,702,863 in expenses, with contributions making up 42.7% of revenue.
Organization's mission or most significant activities as an affiliate of the Georgia institute of technology Southern Light Rail inc (dba southern crossroads or sox) is to facilitate access to current and future highly integrated, digital communication services for education, research and economic development within the southeast region, across the united states and abroad. The organization provides the education and research community with connectivity services to various networks including the internet2 network and the energy sciences network. The organization also offers commodity internet access and network monitoring, engineering and technical support services to participants of the organization.
Main program · fiscal year 2024
Southern Light Rail is designed to facilitate access to current and future highly integrated, digital communication services for education, research and economic development within the southeast, the united states and abroad. Currently, there are (28) single participants, (3) State aggregators, (2) Federal agency participants and (1) Non-profit genomic research agency. This is in addition to (130)… Read more
Southern Light Rail is designed to facilitate access to current and future highly integrated, digital communication services for education, research and economic development within the southeast, the united states and abroad. Currently, there are (28) single participants, (3) State aggregators, (2) Federal agency participants and (1) Non-profit genomic research agency. This is in addition to (130) network port connections to both participant and their affiliated organizations to enhance and catalyze innovative research and development into next generation network technologies, protocols, services and applications.
$3,018,732 spent
Where each dollar went · fiscal year 2024
Of every dollar it spent, 89¢ went to programs, 11¢ to management and 0¢ to fundraising.
Programs $3,018,732
Management $374,583
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
88%
Meets
Compared with Atlanta peers
Measure
This organization
Peer median
Operating reserves
16.5 mo
7.8 mo
Typical margin
+2.3%
−3.0%
Spending growth
+8.2% / yr
+13.1% / yr
Debt load
3.7%
17.8%
Peers: the 12 Atlanta medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$3,865,463Fiscal year 2025
Expenses$3,702,863Fiscal year 2025
Total assets$5,269,992Fiscal year 2025
Total liabilities$192,595Fiscal year 2025
Fiscal year ending June2025
Revenue$3,865,463
Expenses$3,702,863
Net income$162,600
Net assets$5,077,397
Notable sources of revenue
Percent of total revenue
Contributions
$1,650,000
42.7%
Program services
$1,999,413
51.7%
Investment income
$216,050
5.6%
Other (net)
$0
0.0%
Assets / debt
Total assets
$5,269,992
Total liabilities
$192,595
Net assets
$5,077,397
Compensation
Not in our extract for this year.
Fiscal year ending June2024
Revenue$3,447,283
Expenses$3,393,315
Net income$53,968
Net assets$4,914,797
Notable sources of revenue
Percent of total revenue
Contributions
$1,576,048
45.7%
Program services
$1,694,520
49.2%
Investment income
$176,715
5.1%
Other (net)
$0
0.0%
Assets / debt
Total assets
$5,446,186
Total liabilities
$531,389
Net assets
$4,914,797
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$3,034,607
Expenses$2,961,505
Net income$73,102
Net assets$4,860,829
Notable sources of revenue
Percent of total revenue
Contributions
$1,515,000
49.9%
Program services
$1,425,966
47.0%
Investment income
$93,641
3.1%
Other (net)
$0
0.0%
Assets / debt
Total assets
$5,012,073
Total liabilities
$151,244
Net assets
$4,860,829
Compensation
Not in our extract for this year.
Fiscal year ending June2022
Revenue$2,986,549
Expenses$2,926,662
Net income$59,887
Net assets$4,805,160
Notable sources of revenue
Percent of total revenue
Contributions
$1,463,239
49.0%
Program services
$1,557,131
52.1%
Investment income
−$33,821
−1.1%
Other (net)
$0
0.0%
Assets / debt
Total assets
$5,040,316
Total liabilities
$235,156
Net assets
$4,805,160
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?